Goldman Sachs’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.1K | Buy |
27,824
+1,344
| +5% | +$2.04K | ﹤0.01% | 6317 |
|
|
2025
Q4 | $34.7K | Buy |
+26,480
| New | +$36.5K | ﹤0.01% | 6313 |
|
|
2024
Q4 | – | Sell |
-10,246
| Closed | -$21.5K | – | 6186 |
|
|
2024
Q3 | $21.5K | Buy |
+10,246
| New | +$15.2K | ﹤0.01% | 5669 |
|
|
2024
Q1 | – | Sell |
-10,944
| Closed | -$16.4K | – | 5758 |
|
|
2023
Q4 | $16.4K | Buy |
+10,944
| New | +$19.8K | ﹤0.01% | 5458 |
|
|
2023
Q2 | – | Sell |
-22,702
| Closed | -$49K | – | 5946 |
|
|
2023
Q1 | $49K | Sell |
22,702
-28,317
| -56% | -$64.9K | ﹤0.01% | 5559 |
|
|
2022
Q4 | $105K | Buy |
+51,019
| New | +$113K | ﹤0.01% | 5473 |
|
|
2022
Q1 | – | Sell |
-33,516
| Closed | -$90K | – | 6778 |
|
|
2021
Q4 | $90K | Sell |
33,516
-869
| -3% | -$2.9K | ﹤0.01% | 6162 |
|
|
2021
Q3 | $130K | Sell |
34,385
-48,439
| -58% | -$184K | ﹤0.01% | 5864 |
|
|
2021
Q2 | $352K | Buy |
82,824
+19,118
| +30% | +$82.4K | ﹤0.01% | 5429 |
|
|
2021
Q1 | $321K | Buy |
63,706
+4,489
| +8% | +$26.1K | ﹤0.01% | 5396 |
|
|
2020
Q4 | $311K | Buy |
59,217
+45,302
| +326% | +$260K | ﹤0.01% | 4868 |
|
|
2020
Q3 | $73K | Sell |
13,915
-14,651
| -51% | -$84.5K | ﹤0.01% | 5133 |
|
|
2020
Q2 | $155K | Sell |
28,566
-1,915
| -6% | -$10.2K | ﹤0.01% | 4883 |
|
|
2020
Q1 | $113K | Sell |
30,481
-24,909
| -45% | -$130K | ﹤0.01% | 4911 |
|
|
2019
Q4 | $373K | Buy |
55,390
+16,160
| +41% | +$122K | ﹤0.01% | 4652 |
|
|
2019
Q3 | $312K | Sell |
39,230
-3,487
| -8% | -$31.1K | ﹤0.01% | 4669 |
|
|
2019
Q2 | $411K | Sell |
42,717
-6,111
| -13% | -$64.4K | ﹤0.01% | 4476 |
|
|
2019
Q1 | $404K | Sell |
48,828
-46,495
| -49% | -$405K | ﹤0.01% | 4508 |
|
|
2018
Q4 | $779K | Buy |
+95,323
| New | +$951K | ﹤0.01% | 4111 |
|
|
2018
Q3 | – | Sell |
-12,706
| Closed | -$101K | – | 5717 |
|
|
2018
Q2 | $101K | Buy |
+12,706
| New | +$131K | ﹤0.01% | 5213 |
|
|
2017
Q4 | – | Sell |
-25,863
| Closed | -$165K | – | 6533 |
|
|
2017
Q3 | $165K | Sell |
25,863
-21,793
| -46% | -$116K | ﹤0.01% | 5865 |
|
|
2017
Q2 | $251K | Buy |
47,656
+20,567
| +76% | +$115K | ﹤0.01% | 5641 |
|
|
2017
Q1 | $162K | Sell |
27,089
-760
| -3% | -$4.58K | ﹤0.01% | 5836 |
|
|
2016
Q4 | $168K | Buy |
+27,849
| New | +$196K | ﹤0.01% | 5884 |
|
|
2016
Q2 | – | Sell |
-35,000
| Closed | -$257K | – | 7158 |
|
|
2016
Q1 | $257K | Buy |
+35,000
| New | +$173K | ﹤0.01% | 5392 |
|
Other funds holding MNOV
EWM
VCM
VFT
Goldman Sachs's MNOV Position: Q1 2026 in Review
Goldman Sachs increased its MediciNova (MNOV) stake by 5.1% in Q1 2026, buying an estimated $2.04K and bringing the position to 27,824 shares worth $38.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6317.
Goldman Sachs first reported a position in MNOV in Q1 2016 and has held it in 25 quarters since. The position peaked at $779K in Q4 2018. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.
- Goldman Sachs held 27,824 shares of MediciNova worth $38.1K as of Q1 2026.
- Goldman Sachs bought 1,344 MediciNova shares in Q1 2026, an estimated $2.04K.
- MediciNova made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6317 holding.
- Goldman Sachs first reported a position in MediciNova in Q1 2016 and has held it in 25 quarters since.
- Goldman Sachs's MediciNova position peaked at $779K in Q4 2018.
- 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.